C J Melief - Concepedia

Author

C J Melief

Also Known As

C J M MELIEF, C J M Melief, C J Melief, C Melief, C. J. M. MELIEF, C. J. M. Melief, C. Melief, C.J.M Melief, C.J.M. Melief, CJM Melief

Publications

2.2K

Citations

H-Index

Concepts

All Affiliations

Leiden University Dutch Blood Transfusion Society The Netherlands Cancer Institute University of Amsterdam Oncode Institute

About

C J Melief is an author at Leiden University specializing in medicine, immunology, and immunotherapy.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	16	17	1.3K
2	Cell Biology	8	8	558
3	Allergy	3	3	122
4	Health Sciences	2	2	275
5	Public Health	2	2	274

C J Melief

Publications

2.1K

Citations

H-Index

Page 1

	Year	Citations
Immunogenicity of peptides bound to MHC class I molecules depends on the MHC-peptide complex stability Sjoerd H. van der Burg, Marjan J.W. Visseren, Remco M.P. Brandt, The Journal of Immunology	1996	391
Vaccination with HPV16 peptides of patients with advanced cervical carcinoma: clinical evaluation of a phase I–II trial Willemien J. van Driel, Maaike E. Ressing, Gemma G. Kenter, European Journal of Cancer VaccinationCancer-associated VirusVaccine DevelopmentCervical HealthCervical Cancer	1999	230
Antigen capture and major histocompatibility class II compartments of freshly isolated and cultured human blood dendritic cells. Hans W. Nijman, Monique J. Kleijmeer, Miriam A. Ossevoort, The Journal of Experimental Medicine HistocompatibilityImmunohematologyClass IiBlood DcImmunology	1995	183
Antibodies against p53 are associated with poor prognosis of colorectal cancer JGA Houbiers, SH van der Burg, LMG van de Watering, British Journal of Cancer Tumor BiologyOncologyMedicineImmunologyColorectal Cancer	1995	143
CTL specific for the tyrosinase autoantigen can be induced from healthy donor blood to lyse melanoma cells. Marjan J.W. Visseren, A van Elsas, E.I. van der Voort, The Journal of Immunology	1995	123
Evidence for a protective role of interferon in resistance to murine cytomegalovirus and its control by non-H-2-linked genes J. E. Grundy, Jan Trapman, Jane E. Allan, Infection and Immunity Non-h-2-linked GenesType 1Natural Killer CellsViral PersistenceMolecular Virology	1982	100
Characterization of HLA-B57-restricted human immunodeficiency virus type 1 Gag- and RT-specific cytotoxic T lymphocyte responses. Michèl R. Klein, C J Melief, A M Holwerda, Journal of General Virology	1998	99
Initial experience with treatment of human B cell lymphoma with anti-CD19 monoclonal antibody Annemarie Hekman, A. Honselaar, Wim M.J. Vuist, Cancer Immunology Immunotherapy Hematological MalignancyLymphoid NeoplasiaAnti-cd19 Monoclonal AntibodyImmunologyHematology	1991	92
An HLA class I peptide-binding assay based on competition for binding to class I molecules on intact human B cells Sjoerd H. van der Burg, Elisabeth Ras, Jan W. Drijfhout, Human Immunology HistocompatibilityHuman Leukocyte AntigenPeptide LibraryHla ImmunogeneticsImmunology	1995	90
Functional properties of T cells in patients with chronic T gamma lymphocytosis and chronic T cell neoplasia. H C Rümke, Frank Miedema, I J ten Berge, The Journal of Immunology Recurrent InfectionsFunctional PropertiesT-regulatory CellImmunologyImmune Regulation	1982	77

Page 1